From GlobeNewswire: 2024-03-28 07:30:00

The global anesthesia and respiratory devices market is set to grow from USD 43.5 billion in 2023 to USD 77.9 billion by 2033, with a 6.0% CAGR. Anesthesia and respiratory devices play a crucial role in managing patient care during surgeries and respiratory diseases. Factors driving market growth include the aging population, increased prevalence of respiratory diseases, and investments in healthcare facilities. However, challenges such as undiagnosed populations and low acceptance of new technologies may impede market growth. Respiratory devices are expected to dominate the market, fueled by the rising prevalence of respiratory disorders globally. The hospitals segment is poised to grow rapidly due to the demand for advanced medical care services. North America is anticipated to lead the market due to its advanced healthcare infrastructure, while Asia-Pacific is expected to grow the fastest, driven by economic development and increasing government funding for R&D. Major players in the market include Becton, ICU Medical Inc., and Medtronic plc. In recent developments, Medtronic and GE Healthcare announced a collaboration focused on ASCs and OBLs, offering customers access to comprehensive product portfolios and financial solutions. With extensive growth opportunities and innovative developments, the global anesthesia and respiratory devices market is poised for significant expansion in the coming years.



Read more at GlobeNewswire: Global Anesthesia and Respiratory Devices Market Size To